Browsing Tag
antiviral development
3 posts
Does host-pathway targeting offer a durable COVID-19 strategy for Bioxytran, Inc.?
Bioxytran, Inc. reports early ProLectin-M data. Explore what host-targeted antivirals mean for COVID-19 strategy and biotech investors.
Island Pharmaceuticals (ASX: ILA) targets Marburg stockpile deal after FDA greenlights Animal Rule
Island Pharmaceuticals gets FDA Animal Rule nod for Galidesivir in Marburg. Find out how it could unlock US$155M in value and stockpile contracts.
Is Island Pharmaceuticals (ASX: ILA) set for a breakout? Galidesivir awaits critical FDA decision
Island Pharmaceuticals secures FDA response timeline for Galidesivir. Find out how it may accelerate Marburg approval under the Animal Rule pathway.